Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accenture’s 300-page SEC disclosures can bury the datapoints that move the stock—cloud revenue mix, new bookings, and how many consultants billable hours really grew. Finding those nuggets across a dense 10-K, multiple 10-Q updates, and rapid-fire 8-K acquisitions is the challenge every ACN investor faces.
Stock Titan solves that problem by marrying real-time EDGAR feeds with AI-powered summaries that translate complex language into clear takeaways. Need the next Accenture quarterly earnings report 10-Q filing? It lands here seconds after the SEC posts it, alongside a plain-English breakdown of segment margins and headcount trends. Curious about Accenture insider trading Form 4 transactions? Our dashboard flags executive buys and sells the moment they’re filed, complete with historical context.
Explore every disclosure type in one place:
- Annual report 10-K—see how consulting versus managed-services revenue shifts, with Accenture annual report 10-K simplified by AI.
- Quarterly 10-Q—track bookings momentum and free-cash-flow swings.
- 8-K material events—instant reads on acquisitions, leadership changes, or dividend announcements: Accenture 8-K material events explained.
- Proxy statement—understand Accenture proxy statement executive compensation without sifting through tables.
- Form 4—monitor Accenture executive stock transactions Form 4 in real time.
Whether you’re modeling cash flow, comparing segment profitability, or watching Accenture Form 4 insider transactions real-time, Stock Titan delivers the data and plain-language insight you need—no PDF spelunking required.
Accenture plc (ACN) Form 4: Atsushi Egawa, listed as Co-CEO Asia Pacific and an officer of Accenture, reported a transaction dated 08/15/2025. The filing shows a grant of restricted share units (RSUs) issued pursuant to anti-dilution provisions tied to previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists Class A ordinary shares related to the RSU grant and indicates an acquisition event. The form was signed by an attorney-in-fact on 08/18/2025. The filing discloses direct and indirect holdings, including shares held by an immediate family member.
Insider transaction at Accenture plc (ACN): Angie Y. Park, listed as Chief Financial Officer and reporting person, acquired restricted share units on 08/15/2025 under a grant described as anti-dilution adjustments related to Accenture's cash dividend. The Form 4 reports a transaction coded "A" with a price shown as $247.57 and a reported post-transaction beneficial ownership of 7,762 Class A ordinary shares. The filing is signed by an attorney-in-fact on 08/18/2025.
Manish Sharma, an officer (CEO-The Americas) of Accenture plc (ACN), reported a change in beneficial ownership on Form 4. On 08/15/2025 the filing records a non-derivative transaction tied to Class A ordinary shares showing a price of $247.57 and a reported transaction code indicating acquisition under an award. The explanatory note states these were Restricted Share Units (RSUs) granted pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture's payment of a cash dividend. Following the reported transaction(s), the filing shows 1,740 shares beneficially owned in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
Julie Spellman Sweet, Chair and CEO of Accenture plc (ACN), received restricted share units (RSUs) on 08/15/2025 as recorded on this Form 4. The filing shows an acquisition coded as "A" related to anti-dilution adjustments for previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists a unit price of $247.57 and indicates 8,288 Class A ordinary shares beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on behalf of Ms. Sweet on 08/18/2025.
Insider grant recorded for Accenture plc (ACN) — John F. Walsh, listed as Chief Operating Officer and reporting person, reported a transaction dated 08/15/2025 showing restricted share units granted under anti-dilution provisions tied to a cash dividend. The Form 4 reports 16,190 Class A ordinary shares as the amount of securities beneficially owned following the reported transaction. The filing is signed by an attorney-in-fact on behalf of Mr. Walsh and notes the grant was a mechanical adjustment to prior RSU awards to reflect Accenture’s dividend payment.
Joel Unruch, General Counsel and Corporate Secretary of Accenture plc (ticker: ACN), reported a non-derivative transaction dated 08/15/2025. The filing shows a grant of 48 Class A ordinary share units (RSUs) at a reported price of $247.57, recorded as acquired under code A and described as an anti-dilution adjustment to previously granted RSU awards to reflect Accenture's payment of a cash dividend. After the reported transaction, Mr. Unruch is shown as beneficially owning 17,699 Class A ordinary shares, held directly. The form is signed on behalf of Mr. Unruch by an attorney-in-fact on 08/18/2025.
Accenture insider reported an award of restricted share units (RSUs) tied to a dividend adjustment. Melissa A. Burgum, Chief Accounting Officer, reported a transaction dated 08/15/2025 showing an RSU grant described as an anti-dilution adjustment to reflect Accenture plc's cash dividend.
The filing shows a price reference of $247.57 and reports 9,407 Class A ordinary shares beneficially owned following the reported transaction. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
Angela Beatty, Accenture plc Chief Leadership & HR Officer, reported a non-derivative acquisition on 08/15/2025. The Form 4 shows an acquisition (A) of 28 Class A ordinary share units at a price of $247.57, and reports 5,277 Class A ordinary shares beneficially owned following the transaction. The filing explains these units were restricted share units (RSUs) granted pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture's cash dividend. The Form was signed by an attorney-in-fact on behalf of Beatty on 08/18/2025.
Transaction: On 08/05/2025 Manish Sharma, an officer of Accenture plc (title listed as CEO-The Americas), purchased 73 Class A ordinary shares of Accenture (ACN) at $250.74 per share pursuant to the Accenture Voluntary Equity Investment Program.
Holdings and form details: Following the purchase the reporting person beneficially owned 1,731 Class A ordinary shares (Direct). No derivative securities are reported. The Form 4 was signed by attorney-in-fact Danika Haueisen on 08/06/2025.
FAQ
What is the current stock price of Accenture Plc Ireland (ACN)?
What is the market cap of Accenture Plc Ireland (ACN)?
